| Market Cap | 329.19M | P/E | - | EPS this Y | -766.70% | Ern Qtrly Grth | - |
| Income | -192.37M | Forward P/E | -55.93 | EPS next Y | 5.80% | 50D Avg Chg | -15.00% |
| Sales | 324.01M | PEG | -0.75 | EPS past 5Y | -42.23% | 200D Avg Chg | -28.00% |
| Dividend | N/A | Price/Book | 0.88 | EPS next 5Y | 15.00% | 52W High Chg | -66.00% |
| Recommedations | 1.70 | Quick Ratio | 1.49 | Shares Outstanding | 40.05M | 52W Low Chg | 3.00% |
| Insider Own | 5.00% | ROA | -4.81% | Shares Float | 38.89M | Beta | 0.68 |
| Inst Own | 91.25% | ROE | -62.42% | Shares Shorted/Prior | 2.18M/2.46M | Price | 8.39 |
| Gross Margin | 49.27% | Profit Margin | -59.37% | Avg. Volume | 370,435 | Target Price | 13.50 |
| Oper. Margin | -19.28% | Earnings Date | Jul 10 | Volume | 252,090 | Change | -2.44% |
AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
| Oppenheimer | Outperform | Apr 5, 24 |
| Raymond James | Outperform | Jan 9, 24 |
| HC Wainwright & Co. | Buy | Jan 8, 24 |
| Raymond James | Outperform | Oct 6, 23 |
| Canaccord Genuity | Buy | Oct 5, 23 |
| HC Wainwright & Co. | Buy | Oct 5, 23 |
| HC Wainwright & Co. | Buy | Sep 25, 23 |
| Canaccord Genuity | Buy | Jul 13, 23 |
| Raymond James | Outperform | Apr 17, 23 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Helsel Dave | SVP Global Operation.. SVP Global Operations and R&D | Apr 28 | Sell | 22.44 | 3,513 | 78,832 | 22,874 | 05/02/22 |
| DONNELLY HOWARD W | Director Director | Apr 20 | Option | 15.95 | 6,022 | 96,051 | 104,734 | 04/21/22 |
| JOHNSON WESLEY | Director Director | Apr 11 | Sell | 23.13 | 7,500 | 173,475 | 79,704 | 04/13/22 |
| Trowbridge Stephen A | EVP and CFO EVP and CFO | Jan 12 | Buy | 22.64 | 1,000 | 22,640 | 76,081 | 01/12/22 |
| Clemmer James C | President and CEO President and CEO | Jan 11 | Buy | 22.84 | 10,000 | 228,400 | 390,764 | 01/12/22 |
| Centea Scott | Sr. VP/GM, Global VI.. Sr. VP/GM, Global VIT | Oct 15 | Option | 16.77 | 12,000 | 201,240 | 58,244 | 10/18/21 |
| Centea Scott | Sr. VP/GM, Global VI.. Sr. VP/GM, Global VIT | Oct 15 | Sell | 27.92 | 12,000 | 335,040 | 46,244 | 10/18/21 |
| Meteny Dennis S | Director Director | Jul 30 | Option | 14.64 | 5,726 | 83,829 | 117,865 | 07/30/21 |
| Trowbridge Stephen A | EVP and CFO EVP and CFO | Apr 16 | Option | 14.07 | 13,625 | 191,704 | 73,371 | 04/16/21 |
| DONNELLY HOWARD W | Director Director | Apr 05 | Option | 14.64 | 5,726 | 83,829 | 96,595 | 04/05/21 |